Accomplished Public Health Consultant with over 10 years experience in programmatic management of TB and Drug resistant TB in low and middle income countries. Demonstrated technical leadership, program management, strategic planning, and policy experience. Strong background in the public health programming, health system research with intersection of public health and technology, with a focus on strengthening the health system.
1. Osman E,Daniel et al.. Resistance of mycobacterium tuberculosis to first and second line anti-tuberculosis drug in South West, Nigeria. Journal of Pulmonary and Respiratory Medicine 2012; S6:001.
2. Daniel OJ, Bamidele JO, Sodeinde JK, Ekundayo AA, Salako AA. Rifampicin resistance among patients with Tuberculosis at the Olabisi Onabanjo University Teaching Hospital, Sagamu. Annals of Health Research 2018: 4 (1), 53-59
3. AM, Udunze OC, Bamidele JO, Omoniyi A, Osman E, Daniel OJ. Outcome of community-initiated treatment of drug-resistant tuberculosis patients in Lagos, Nigeria. Transactions of The Royal Society of Tropical Medicine and Hygiene 2020: 115 (9)
4. Okapi O, Adejumo OA, Redwood L, Okorie O , Lawale O , Azuogu B, Gidado M, Daniel OJ ,Mitchell EMH. Community health care workers in pursuit of TB: Discourses and dilemmas Social Science & Medicine 2020: 246112756
5. Adejumo OA, Daniel OJ, Adepoju VA, Onoh M, Sokoya O, Abdulr-Razzaq HA, Moronfolu O, Oyadotun OM, Faleye BO. Pre-treatment attrition and treatment initiation delay among rifampicin-resistant tuberculosis patients in Lagos Nigeria: A retrospective cohort study Transactions of The Royal Society of Tropical Medicine and Hygiene 2022;116:1154-1161